DrugPatentWatch Database Preview
Profile for Slovenia Patent: 2223687
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Slovenia Patent: 2223687
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Mar 19, 2023 | Celgene Corp | OTEZLA | apremilast |
Start Trial | Mar 19, 2023 | Celgene Corp | OTEZLA | apremilast |
Start Trial | Feb 16, 2028 | Celgene Corp | OTEZLA | apremilast |
Start Trial | Mar 19, 2023 | Celgene Corp | OTEZLA | apremilast |
Start Trial | Dec 9, 2023 | Celgene Corp | OTEZLA | apremilast |
Start Trial | Mar 19, 2023 | Celgene Corp | OTEZLA | apremilast |
Start Trial | Mar 19, 2023 | Celgene Corp | OTEZLA | apremilast |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |